UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties

European journal of pharmacology, 2006-09, Vol.546 (1-3), p.88-94

2006

Volltextzugriff (PDF)

CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Journal of medicinal chemistry, 2003-09, Vol.46 (19), p.4070-4086

2003

Volltextzugriff (PDF)

Reverse Cope Elimination of Hydroxylamines and Alkenes or Alkynes: Theoretical Investigation of Tether Length and Substituent Effects

Journal of the American Chemical Society, 2012-02, Vol.134 (4), p.2434-2441

2012

Volltextzugriff (PDF)

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

Molecular pharmacology, 2006-01, Vol.69 (1), p.236

2006

Volltextzugriff (PDF)

6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT2C Receptor Antagonist

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3494-3496

1997

Volltextzugriff (PDF)

Identification of a novel series of selective 5-HT7 receptor antagonists

Bioorganic & medicinal chemistry letters, 2003-03, Vol.13 (6), p.1055-1058

2003

Volltextzugriff (PDF)

Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists

ACS medicinal chemistry letters, 2010-09, Vol.1 (6), p.244-248

2010

Volltextzugriff (PDF)

SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats

British journal of pharmacology, 2003-06, Vol.139 (4), p.705-714

2003

Volltextzugriff (PDF)

A Novel, Potent, and Selective 5-HT7 Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

Journal of medicinal chemistry, 2000-02, Vol.43 (3), p.342-345

2000

Volltextzugriff (PDF)

2′ Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling

Bioorganic & medicinal chemistry letters, 2010-06, Vol.20 (12), p.3545-3549

2010

Volltextzugriff (PDF)

The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5434-5438

2010

Volltextzugriff (PDF)

N-(1-Methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: A Novel, High-Affinity 5-HT2B Receptor Antagonist

Journal of medicinal chemistry, 1995-03, Vol.38 (6), p.855-857

1995

Volltextzugriff (PDF)

Studies towards the identification of a new generation of atypical antipsychotic agents

Bioorganic & medicinal chemistry letters, 2007-01, Vol.17 (2), p.400-405

2007

Volltextzugriff (PDF)

2′ Biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR

Bioorganic & medicinal chemistry letters, 2010-06, Vol.20 (12), p.3540-3544

2010

Volltextzugriff (PDF)

Efficient Route for the Preparation of Benzyloxy-Substituted Benzenesulfonyl Chlorides from Mercaptophenols

Synthetic communications, 2011-05, Vol.41 (12), p.1805-1808

2011

Volltextzugriff (PDF)

SB-656104-A: A novel 5-HT7 receptor antagonist with improved in vivo properties

Bioorganic & medicinal chemistry letters, 2002-11, Vol.12 (22), p.3341-3344

2002

Volltextzugriff (PDF)

Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719

British journal of pharmacology, 1998-07, Vol.124 (6), p.1300-1306

1998

Volltextzugriff (PDF)

A short and efficient synthesis of N-substituted indol-2-ones (oxindoles)

Tetrahedron letters, 2001-09, Vol.42 (39), p.6943-6945

Forbes, Ian T

2001

Volltextzugriff (PDF)

Indium(III)-catalysed aryl sulfonylation reactions

Tetrahedron letters, 2004-02, Vol.45 (7), p.1499-1501

2004

Volltextzugriff (PDF)

(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7 Receptor Antagonist

Journal of medicinal chemistry, 1998-02, Vol.41 (5), p.655-657

1998

Volltextzugriff (PDF)

Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists

Bioorganic & medicinal chemistry letters, 2001-08, Vol.11 (16), p.2177-2180

2001

Volltextzugriff (PDF)

CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound

Bioorganic & medicinal chemistry letters, 2000-08, Vol.10 (16), p.1803-1806

2000

Volltextzugriff (PDF)

Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines

Journal of medicinal chemistry, 1998-05, Vol.41 (10), p.1598-1612

1998

Volltextzugriff (PDF)

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity

Journal of medicinal chemistry, 1995-07, Vol.38 (14), p.2524-2530

1995

Volltextzugriff (PDF)

1 – 25 von 709

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(607)
Mit Volltextzugriff
(556)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Crop Science
(32)
Journal Of Medicinal Chemistry
(18)
Bioorganic & Medicinal Chemistry Letters
(17)
Agronomy Journal
(16)
Journal Of Clinical Oncology
(15)
Journal Of Vascular Surgery
(11)
Bmj
(10)
The Lancet
(10)
Cheminform
(8)
Gastrointestinal Endoscopy
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties

CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Reverse Cope Elimination of Hydroxylamines and Alkenes or Alkynes: Theoretical Investigation of Tether Length and Substituent Effects

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT2C Receptor Antagonist

Identification of a novel series of selective 5-HT7 receptor antagonists

Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists

SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats

A Novel, Potent, and Selective 5-HT7 Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

2′ Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling

The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists

N-(1-Methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: A Novel, High-Affinity 5-HT2B Receptor Antagonist

Studies towards the identification of a new generation of atypical antipsychotic agents

2′ Biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR

Efficient Route for the Preparation of Benzyloxy-Substituted Benzenesulfonyl Chlorides from Mercaptophenols

SB-656104-A: A novel 5-HT7 receptor antagonist with improved in vivo properties

Functional characterisation of the human cloned 5‐HT7 receptor (long form); antagonist profile of SB‐258719

A short and efficient synthesis of N-substituted indol-2-ones (oxindoles)

Indium(III)-catalysed aryl sulfonylation reactions

(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7 Receptor Antagonist

Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists: Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent

Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists

CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound

Novel and Selective 5-HT2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity

Suchergebnisse filtern